Ferring Pharmaceuticals today welcomes the Swissmedic approval of Carbetocin Ferring, a heat-stable formulation of carbetocin, for the prevention of excessive bleeding after childbirth following all births, both vaginal and caesarean section. Read the full article HERE.
Swissmedic approves Carbetocin Ferring for the prevention of postpartum haemorrhage in all births
May 13, 2020
